BofA Global Research has reaffirmed its cautious stance on Yanbu National Petrochemical (Yansab), even as it nudged its price target higher. The bank lifted its target to 30 Saudi riyals per share but kept an “underperform” rating, signaling that it still sees more downside than upside for the stock.
The move comes as part of a broader review of chemicals companies in the Middle East and North Africa. In its note, BofA pointed to a persistent oversupply in the global market for mono-ethylene glycol (MEG), a key industrial chemical used to make polyester fibers, antifreeze, and packaging materials. The glut, the bank argues, is being driven largely by new production capacity coming online in China and the United States.
Why MEG prices are under pressure
MEG is a commodity chemical, meaning its price is heavily influenced by global supply and demand rather than by any single producer. Over the past few years, China has expanded its own MEG production capacity significantly, reducing its reliance on imports. At the same time, U.S. producers have added capacity thanks to cheap natural gas feedstocks.
BofA notes that Chinese demand has been “resilient” enough to keep plants running, but not strong enough to absorb the wave of new supply. That combination typically leads to oversupply, which pushes prices down. For producers like Yansab, lower MEG prices directly hit their “netbacks” — the revenue they earn per ton after accounting for production and logistics costs.
The bank’s view is that this pressure will persist in the medium term, even if there are occasional short-term price rallies. That is why it is sticking with an underperform rating despite raising its price target. The higher target likely reflects a slightly improved near-term outlook or a more favorable currency assumption, but the overall message remains cautious.
What this means for investors
For everyday investors, the key takeaway is that BofA sees limited upside for Yansab shares over the next year. The 30-riyal target may be above the current trading price, but the underperform rating suggests the bank expects the stock to lag the broader market or its peers.
Yansab is one of Saudi Arabia’s largest petrochemical producers, and its fortunes are closely tied to the global chemicals cycle. When MEG and other product prices are weak, margins shrink, and so do profits. Investors who hold Yansab shares — or who are considering buying them — should be aware that the company’s earnings are sensitive to these global price swings.
BofA’s caution on Yansab is part of a wider theme in the sector. The bank has also maintained a bearish view on other Saudi petrochemical names, such as Saudi Kayan, citing valuation, debt, and shipping costs. Similarly, it recently trimmed its target on SABIC due to shipping risks delaying a volume recovery. These moves suggest that BofA sees headwinds across the Saudi chemicals sector, not just at Yansab.
However, not all chemical companies are viewed the same way. For instance, BofA has a more positive stance on some names, such as Sabic Agri-Nutrients, where it sees urea prices supported into 2027. And it has kept a buy rating on Sipchem despite a target cut, citing volume growth. This shows that the bank is differentiating between companies based on their product mix and exposure to different chemicals.
The bigger picture
The chemicals industry is cyclical, and investors should expect volatility. When global economic growth is strong, demand for chemicals rises, and prices firm up. When growth slows, or when new supply floods the market, prices can fall sharply. The current situation is a classic supply-driven downturn: capacity additions are outpacing demand growth.
For Yansab, the medium-term outlook depends on how quickly the oversupply is absorbed. That could happen if demand accelerates, if some high-cost producers shut down, or if new capacity is delayed. But BofA’s analysis suggests that none of these are likely to happen soon.
For investors, the practical implication is to be cautious about expecting a strong recovery in Yansab’s share price in the near term. The stock may still pay a dividend, and the company has a solid balance sheet, but earnings growth is likely to be limited while MEG prices remain soft.
As always, it’s important to remember that analyst ratings are just one opinion. They are based on a set of assumptions that can change. But when a major bank like BofA sticks with a bearish view, it’s worth paying attention to the reasoning — especially when it points to structural oversupply that could take years to resolve.
